Replies to post #107198 on Biotech Values

[jq1234]

I don't remember another company tried to start post-approval type pivotal trial for sNDA even before NDA was submitted. VRTX basically tries to demonstrate noninferiority to a drug that not even submitted NDA.

[genisi]

I think that the on treatment response-guided therapy in this study is based on negative HCV RNA at week 4 only.